Quantum Pharma Plc CFO purchases shares in the PLC

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier to the health and care sectors, announces that on 3 January 2017 the Company was notified that Gerard Murray, Quantum’s Chief Financial Officer Designate, purchased 200,000 Ordinary Shares of 10 pence each in the Company at a price of 44.75 pence per Ordinary Share on 3 January 2017.  Following this transaction, Gerard Murray holds 200,000 Ordinary Shares representing approximately 0.12% of the issued share capital of the Company.

 

As announced on 8 December 2016, Gerard will join Quantum on 23 January 2017 from Ardent Hire Solutions Limited, a private equity backed plant hire business, where he has been the CFO since April 2016.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Quantum Pharma Plc

    More articles like this

    Quantum Pharma Plc

    Quantum Pharma Plc FY17 Results – A Year of Change

    Quantum Pharma plc (LON:QP), the service-led niche pharmaceutical developer and supplier to the health and care sectors, has reported its Preliminary financial results for the 12 months to January 31, 2017. Net sales grew by 28%

    Quantum Pharma Plc

    Quantum Pharma PLC makes strategic financial appointment

    County Durham based Quantum Pharma has bolstered its executive team with the help of business advisers UNW. The niche pharmaceutical developer and manufacturer, which supplies a range of innovative products to wholesalers, retailers and hospitals, approached

    Quantum Pharma Plc

    Quantum Pharma reduces debt after taking strategic action

    Niche pharma firm Quantum Pharma says it is on target to meet market expectations after taking action to tighten its focus. The Burnopfield pharmaceutical developer , manufacturer and supplier issued a trading update for the year

    Quantum Pharma Plc

    Quantum Pharma PLC Pre-close trading update – on plan

    Quantum Pharma plc (LON:QP), the service-led niche pharmaceutical manufacturer, developer and supplier to the health and care sectors, has released a pre-close trading update this morning. Zeus Capital said: The Board has indicated that adjusted EBITDA

    DirectorsTalk

    Quantum Pharma Plc “A good first half year”

    Quantum Pharma Plc (AIM: QP.), the growing, service-led niche pharmaceutical manufacturer, developer and supplier to the health and care sectors, has today given DirectorsTalk its half year results for the six months to 31 July 2015,